William J. Caragol, PositiveID’s Chairman and CEO, called in to SmallCapVoice.com to talk about current news for the company. PositiveID Corporation (PSID) recently signed a U.S. Special Operations Command (“USSOCOM”) Cooperative Research and Development Agreement (“Agreement”) with Special Operations Research, Development, & Acquisition Center, Science & Technology Directorate (“USSOCOM SORDAC-ST”), to further develop the Company’s real-time PCR (polymerase chain reaction) pathogen detection system, Firefly Dx, for use across the USSOCOM mission space.
About PositiveID Corporation
PositiveID Corporation is an emerging growth company and developer of biological detection systems for America’s homeland defense industry as well as rapid biological testing. PositiveID is focused on the development of microfluidic systems for the automated preparation of and performance of biological assays in order to detect biological threats and analyze biological samples. For more information on PositiveID, please visit http://www.PositiveIDCorp.com.